Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$364,403,654
+$103,672,775 QoQ
Shares Held
303,814
+7.2% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#187
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $2,528,024,463 across 14 Drug Manufacturers - General names. LLY ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,799,159 | $1,218,842,409 | |
| 2 | ABBV |
AbbVie Inc.
|
2,042,445 | $513,960,857 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
303,814 | $364,403,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,064,683 | $136,811,765 | |
| 5 | AMGN |
Amgen Inc
|
339,825 | $123,057,427 | |
| 6 | PFE |
Pfizer Inc
|
2,312,826 | $55,692,848 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
292,295 | $36,928,549 | |
| 8 | AZN |
Astrazeneca PLC
|
134,149 | $25,437,332 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $364,403,654 | 303,814 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $260,730,879 | 283,474 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $296,712,726 | 276,094 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $196,044,457 | 256,939 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $207,798,531 | 266,569 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $215,329,603 | 260,718 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $203,072,284 | 263,047 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $244,579,682 | 276,068 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $237,758,218 | 262,606 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $184,864,299 | 237,627 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $132,120,564 | 226,653 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $115,767,090 | 215,529 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $94,206,824 | 200,876 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $78,620,512 | 228,934 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $82,114,980 | 224,456 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $70,935,551 | 219,377 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $74,565,766 | 229,978 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $73,829,048 | 257,810 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $72,819,601 | 263,629 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $59,438,304 | 257,253 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $60,254,049 | 262,522 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $49,082,470 | 262,726 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $46,776,782 | 277,048 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $39,849,351 | 269,216 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $41,549,687 | 253,074 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $37,040,042 | 267,013 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||